<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7405836\results\search\testTrace\results.xml">
  <result pre="virus, and coronaviruses (CoVs). Recently, a new type of viral" exact="infection" post="emerged in Wuhan City, China, and initial genomic sequencing"/>
  <result pre="virus, and coronaviruses (CoVs). Recently, a new type of viral" exact="infection" post="emerged in Wuhan City, China, and initial genomic sequencing"/>
  <result pre="been transferred from an animal source, such as bats. Early" exact="diagnosis" post="by real-time PCR and next-generation sequencing has facilitated the"/>
  <result pre="to counter this pandemic virus. KEYWORDS COVID-19 emerging coronavirus SARS-CoV-2" exact="diagnosis" post="One Health therapy vaccines fig-count: table-count: equation-count: ref-count: page-count:"/>
  <result pre="of SARS-CoV-2/COVID-19 causing the current disease outbreaks and advances in" exact="diagnosis" post="and developing vaccines and therapeutics. It also provides a"/>
  <result pre="death among individuals infected with COVID-19 was calculated using the" exact="infection" post="fatality risk (IFR). The IFR was found to be"/>
  <result pre="China have been blamed for the origin of novel coronavirus" exact="infection" post="in humans. Previously, the animals present in the live-animal"/>
  <result pre="likely to become severely infected (80). Recently, individuals with asymptomatic" exact="infection" post="were also found to act as a source of"/>
  <result pre="infection were also found to act as a source of" exact="infection" post="to susceptible individuals (81). Both the asymptomatic and symptomatic"/>
  <result pre="Thus, SARS-CoV-2 transmission can happen early in the course of" exact="infection" post="(82). Atypical clinical manifestations have also been reported in"/>
  <result pre="finally end up in the wastewater and sewage sludge of" exact="treatment" post="plants (328). Therefore, we have to reevaluate the current"/>
  <result pre="we have to reevaluate the current wastewater and sewage sludge" exact="treatment" post="procedures and introduce advanced techniques that are specific and"/>
  <result pre="there is active shedding of SARS-CoV-2 in the stool, the" exact="prevalence" post="of infections in a large population can be studied"/>
  <result pre="of SARS-CoV-2 RNA concentrated from wastewater collected from a wastewater" exact="treatment" post="plant (327). The calculated viral RNA copy numbers determine"/>
  <result pre="the fecal route warrants the introduction of negative fecal viral" exact="nucleic acid test" post="results as one of the additional discharge criteria in"/>
  <result pre="infected cases (84). Coronaviruses in Humansâ€&quot;SARS, MERS, and COVID-19 Coronavirus" exact="infection" post="in humans is commonly associated with mild to severe"/>
  <result pre="enlighten our understanding of the lung inflammation associated with this" exact="infection" post="(24). SARS is a viral respiratory disease caused by"/>
  <result pre="palm civet for SARS-CoV and the dromedary camel for MERS-CoV" exact="infection" post="(102). Bats are considered the ancestral hosts for both"/>
  <result pre="in circulation maintains specific â€œpoisedâ€� spike proteins that facilitate human" exact="infection" post="without the requirement of any mutations or adaptations (105)."/>
  <result pre="of recombination (107). The current scientific evidence available on MERS" exact="infection" post="suggests that the significant reservoir host, as well as"/>
  <result pre="reservoir host, as well as the animal source of MERS" exact="infection" post="in humans, is the dromedary camels (97). The infected"/>
  <result pre="possibility of interspecies transmission in SARS-CoV. The higher diversity and" exact="prevalence" post="of bat coronaviruses in this region compared to those"/>
  <result pre="there is a potential risk for the reemergence of SARS-CoV" exact="infection" post="from the viruses that are currently circulating in the"/>
  <result pre="raised doubts for the likelihood of vertical transmission (240â€&quot;243). COVID-19" exact="infection" post="was associated with pneumonia, and some developed acute respiratory"/>
  <result pre="(percent) give an idea about the disease severity in COVID-19" exact="infection" post="(121). During COVID-19, patients may present leukocytosis, leukopenia with"/>
  <result pre="wild animals (20, 30, 79, 93, 124, 125, 287). Coronavirus" exact="infection" post="is linked to different kinds of clinical manifestations, varying"/>
  <result pre="noteworthy morbidity and mortality. Infection with PHEV also causes enteric" exact="infection" post="but can cause encephalitis due to its ability to"/>
  <result pre="species. Additionally, pigs are also found to be susceptible to" exact="infection" post="with human SARS-CoV and MERS-CoV, making this scenario a"/>
  <result pre="The World Organization for Animal Health (OIE) has confirmed the" exact="diagnosis" post="of COVID-19 in both dogs and cats due to"/>
  <result pre="transmission, necessary preventive measures are advised, as well as following" exact="social distancing" post="practices among companion animals of different households (331). One"/>
  <result pre="of the leading veterinary diagnostic companies, IDEXX, has conducted large-scale" exact="testing" post="for COVID-19 in specimens collected from dogs and cats."/>
  <result pre="cats efficiently transmitted the disease to naive cats (329). SARS-CoV-2" exact="infection" post="and subsequent transmission in ferrets were found to recapitulate"/>
  <result pre="(12). DIAGNOSIS OF SARS-CoV-2 (COVID-19) RNA tests can confirm the" exact="diagnosis" post="of SARS-CoV-2 (COVID-19) cases with real-time RT-PCR or next-generation"/>
  <result pre="next-generation sequencing (148, 149, 245, 246). At present, nucleic acid" exact="detection" post="techniques, like RT-PCR, are considered an effective method for"/>
  <result pre="like RT-PCR, are considered an effective method for confirming the" exact="diagnosis" post="in clinical cases of COVID-19 (148). Several companies across"/>
  <result pre="are currently focusing on developing and marketing SARS-CoV-2-specific nucleic acid" exact="detection" post="kits. Multiple laboratories are also developing their own in-house"/>
  <result pre="in-house RT-PCR. One of them is the SARS-CoV-2 nucleic acid" exact="detection" post="kit produced by Shuoshi Biotechnology (double fluorescence PCR method)"/>
  <result pre="(EUAs), including for the RT-PCR diagnostic panel for the universal" exact="detection" post="of SARS-like betacoronaviruses and specific detection of SARS-CoV-2, developed"/>
  <result pre="panel for the universal detection of SARS-like betacoronaviruses and specific" exact="detection" post="of SARS-CoV-2, developed by the U.S. CDC (Table 1)"/>
  <result pre="BioFire COVID-19 test PerkinElmer, Inc. PerkinElmer new coronavirus nucleic acid" exact="detection" post="kit Avellino Lab USA, Inc. AvellinoCoV2 test BGI Genomics,"/>
  <result pre="SARS-CoV (253). SARS-CoV-2 transmission can occur early in the viral" exact="infection" post="phase; thus, diagnosing cases and isolation attempts for this"/>
  <result pre="early in the viral infection phase; thus, diagnosing cases and" exact="isolation" post="attempts for this virus warrant different strategies than those"/>
  <result pre="of data for assessing SARS-CoV-2 transmission dynamics and updating the" exact="screening" post="procedures in the clinics (82). TABLE 2 Clinical specimens"/>
  <result pre="procedures in the clinics (82). TABLE 2 Clinical specimens for" exact="detection" post="of SARS CoV-2 Sample Recommendationa Bronchoalveolar lavage fluid +++"/>
  <result pre="In a recent survey from 17 confirmed cases of SARS-CoV-2" exact="infection" post="with available data (representing days 0 to 13 after"/>
  <result pre="the gastrointestinal symptoms and the possibility of fecal SARS-CoV-2 RNA" exact="detection" post="during the COVID-19 incubation period or convalescence phases of"/>
  <result pre="throat swab, due to their higher positive rate on the" exact="nucleic acid test" post="(148). The diagnosis of COVID-19 can be made by"/>
  <result pre="higher positive rate on the nucleic acid test (148). The" exact="diagnosis" post="of COVID-19 can be made by using upper-respiratory-tract specimens"/>
  <result pre="positive results than oral swabs in the later stages of" exact="infection" post="(153). Hence, clinicians have to be cautious while discharging"/>
  <result pre="SARS-CoV-2 in the stool sample. A suspected case of COVID-19" exact="infection" post="is said to be confirmed if the respiratory tract"/>
  <result pre="confirmative of using saliva as a noninvasive specimen for the" exact="diagnosis" post="of COVID-19 infection in suspected individuals (152). It has"/>
  <result pre="saliva as a noninvasive specimen for the diagnosis of COVID-19" exact="infection" post="in suspected individuals (152). It has also been observed"/>
  <result pre="individuals (152). It has also been observed that the initial" exact="screening" post="of COVID-19 patients infected with RT-PCR may give negative"/>
  <result pre="findings that are suggestive of infection. Hence, for the accurate" exact="diagnosis" post="of COVID-19, a combination of repeated swab tests using"/>
  <result pre="required to prevent the possibility of false-negative results during disease" exact="screening" post="(154). RT-PCR is the most widely used test for"/>
  <result pre="the viral load, we can quickly evaluate the progression of" exact="infection" post="(291). In addition to all of the above findings,"/>
  <result pre="resources and logistical limitations associated with an outbreak (155). SARS-CoV-2" exact="infection" post="can also be confirmed by isolation and culturing. The"/>
  <result pre="an outbreak (155). SARS-CoV-2 infection can also be confirmed by" exact="isolation" post="and culturing. The human airway epithelial cell culture was"/>
  <result pre="The efficient control of an outbreak depends on the rapid" exact="diagnosis" post="of the disease. Recently, in response to the COVID-19"/>
  <result pre="genome (156). That assay was found to achieve the rapid" exact="detection" post="of SARS-CoV-2. Nucleic acid-based assays offer high accuracy in"/>
  <result pre="of SARS-CoV-2. Nucleic acid-based assays offer high accuracy in the" exact="diagnosis" post="of SARS-CoV-2, but the current rate of spread limits"/>
  <result pre="scenario is very important. Radiologists can help in the early" exact="diagnosis" post="of lung abnormalities associated with COVID-19 pneumonia. They can"/>
  <result pre="diagnostic tool for COVID-19, the extensive use of CT for" exact="screening" post="purposes in the suspected individuals might be associated with"/>
  <result pre="risk of cross-infection. Hence, the use of CT for early" exact="diagnosis" post="of SARS-CoV-2 infection in high-risk groups should be done"/>
  <result pre="Hence, the use of CT for early diagnosis of SARS-CoV-2" exact="infection" post="in high-risk groups should be done with great caution"/>
  <result pre="other advanced diagnostics have been designed and developed for the" exact="detection" post="of SARS-CoV-2 (345, 347, 350â€&quot;352). A reverse transcriptional loop-mediated"/>
  <result pre="(RT-LAMP), namely, iLACO, has been developed for rapid and colorimetric" exact="detection" post="of this virus (354). RT-LAMP serves as a simple,"/>
  <result pre="real-time mode has been designed (238). A smartphone-integrated home-based point-of-care" exact="testing" post="(POCT) tool, a paper-based POCT combined with LAMP, is"/>
  <result pre="has been designed as a point-of-care test for very rapid" exact="detection" post="of SARS-CoV-2 in just 5 min (344). A CRISPR-based"/>
  <result pre="CRISPR-based SHERLOCK (specific high-sensitivity enzymatic reporter unlocking) diagnostic for rapid" exact="detection" post="of SARS-CoV-2 without the requirement of specialized instrumentation has"/>
  <result pre="has been reported to be very useful in the clinical" exact="diagnosis" post="of COVID-19 (360). A CRISPR-Cas12-based lateral flow assay also"/>
  <result pre="CRISPR-Cas12-based lateral flow assay also has been developed for rapid" exact="detection" post="of SARS-CoV-2 (346). Artificial intelligence, by means of a"/>
  <result pre="three-dimensional deep-learning model, has been developed for sensitive and specific" exact="diagnosis" post="of COVID-19 via CT images (332). Tracking and mapping"/>
  <result pre="(CHARMS), which could aid in assessing the possibility of getting" exact="infection" post="and estimating the prognosis in patients; however, such models"/>
  <result pre="present scenario, we need to depend solely on implementing effective" exact="infection" post="control measures to lessen the risk of possible nosocomial"/>
  <result pre="or therapeutic drugs against SARS-CoV-2 (293). The majority of the" exact="treatment" post="options and strategies that are being evaluated for SARS-CoV-2"/>
  <result pre="responses (177). Immunoinformatics methods have been employed for the genome-wide" exact="screening" post="of potential vaccine targets among the different immunogens of"/>
  <result pre="expressing SARS-CoV-2 spike protein is likely to go through clinical" exact="testing" post="in the coming months (180). On 16 March 2020,"/>
  <result pre="Therapeutics and Drugs There is no currently licensed specific antiviral" exact="treatment" post="for MERS- and SARS-CoV infections, and the main focus"/>
  <result pre="A controlled trial of ritonavir-boosted lopinavir and interferon alpha 2b" exact="treatment" post="was performed on COVID-19 hospitalized patients (ChiCTR2000029308) (188). In"/>
  <result pre="patients suffering from severe COVID-19 revealed no benefit of lopinavir-ritonavir" exact="treatment" post="over standard care (273). The efforts to control SARS-CoV-2"/>
  <result pre="treatment over standard care (273). The efforts to control SARS-CoV-2" exact="infection" post="utilize defined strategies as followed against MERS and SARS,"/>
  <result pre="this novel virus (36, 189). Presently, the main course of" exact="treatment" post="for severely affected SARS-CoV-2 patients admitted to hospitals includes"/>
  <result pre="revealed remdesivir and chloroquine to be highly effective against SARS-CoV-2" exact="infection" post="in vitro (194). Ribavirin, penciclovir, and favipiravir might not"/>
  <result pre="Further, in vivo studies conducted in mice also identified that" exact="treatment" post="with remdesivir improved pulmonary function and reduced viral loads"/>
  <result pre="pathology both in prophylactic and therapeutic regimens compared to lopinavir/ritonavir-IFN-Î³" exact="treatment" post="in MERS-CoV infection (8). Remdesivir also inhibits a diverse"/>
  <result pre="prophylactic and therapeutic regimens compared to lopinavir/ritonavir-IFN-Î³ treatment in MERS-CoV" exact="infection" post="(8). Remdesivir also inhibits a diverse range of coronaviruses,"/>
  <result pre="has to be further evaluated for its efficacy in the" exact="treatment" post="of COVID-19 infection in humans. The broad-spectrum activity exhibited"/>
  <result pre="further evaluated for its efficacy in the treatment of COVID-19" exact="infection" post="in humans. The broad-spectrum activity exhibited by remdesivir will"/>
  <result pre="SARS-CoV-2-associated pneumonia (197). This drug is already included in the" exact="treatment" post="guidelines issued by the National Health Commission of the"/>
  <result pre="authors raised concerns over the efficacy of hydroxychloroquine-azithromycin in the" exact="treatment" post="of COVID-19 patients, since no observable effect was seen"/>
  <result pre="was seen when they were used. In some cases, the" exact="treatment" post="was discontinued due to the prolongation of the QT"/>
  <result pre="SARS-CoV-2. The findings from this study indicate that a single" exact="treatment" post="of this drug was able to induce an âˆ¼5,000-fold"/>
  <result pre="does not have any sort of inhibitory action against SARS-CoV-2" exact="infection" post="(194). Recently, several newly synthesized halogenated triazole compounds were"/>
  <result pre="recovering from SARS showed robust neutralizing antibodies against this CoV" exact="infection" post="(164). A set of MAbs aimed at the MERS-CoV"/>
  <result pre="or in combination with other effective neutralizing antibodies for the" exact="treatment" post="and prevention of COVID-19 (202). Furthermore, SARS-CoV-specific neutralizing antibodies,"/>
  <result pre="to 250â€‰ml on the day of collection (310). At present," exact="treatment" post="for sepsis and ARDS mainly involves antimicrobial therapy, source"/>
  <result pre="efficacy (311). Potential Therapeutic Agents Potent therapeutics to combat SARS-CoV-2" exact="infection" post="include virus binding molecules, molecules or inhibitors targeting particular"/>
  <result pre="2 level was found to be markedly elevated in COVID-19" exact="infection" post="and was correlated with viral load and lung injury."/>
  <result pre="that block angiotensin receptors may have potential for treating COVID-19" exact="infection" post="(121). A scientist from Germany, named Rolf Hilgenfeld, has"/>
  <result pre="has been working on the identification of drugs for the" exact="treatment" post="of coronaviral infection since the time of the first"/>
  <result pre="on the identification of drugs for the treatment of coronaviral" exact="infection" post="since the time of the first SARS outbreak (19)."/>
  <result pre="mice, and hDPP4-Tg mice (transgenic for expressing hDPP4) for MERS-CoV" exact="infection" post="(221). The CRISPR-Cas9 gene-editing tool has been used for"/>
  <result pre="inserting genomic alterations in mice, making them susceptible to MERS-CoV" exact="infection" post="(222). Efforts are under way to recognize suitable animal"/>
  <result pre="the SARS-CoV-2-infected monkeys without rechallenge. These findings suggest that primary" exact="infection" post="with SARS-CoV-2 could protect from later exposures to the"/>
  <result pre="surrounding provinces as well as to several other countries. Large-scale" exact="screening" post="programs might help us to control the spread of"/>
  <result pre="as well as time-consuming due to the present extent of" exact="infection" post="(226). The current scenario demands effective implementation of vigorous"/>
  <result pre="protection (goggles), gowns, and gloves to nullify the risk of" exact="infection" post="(299). The human-to-human transmission reported in SARS-CoV-2 infection occurs"/>
  <result pre="risk of infection (299). The human-to-human transmission reported in SARS-CoV-2" exact="infection" post="occurs mainly through droplet or direct contact. Due to"/>
  <result pre="to this finding, frontline health care workers should follow stringent" exact="infection" post="control and preventive measures, such as the use of"/>
  <result pre="preventive measures, such as the use of PPE, to prevent" exact="infection" post="(110). The mental health of the medical/health workers who"/>
  <result pre="The effective control of SARS-CoV-2/COVID-19 requires high-level interventions like intensive" exact="contact tracing," post="as well as the quarantine of people with suspected"/>
  <result pre="high-level interventions like intensive contact tracing, as well as the" exact="quarantine" post="of people with suspected infection and the isolation of"/>
  <result pre="tracing, as well as the quarantine of people with suspected" exact="infection" post="and the isolation of infected individuals. The implementation of"/>
  <result pre="as the quarantine of people with suspected infection and the" exact="isolation" post="of infected individuals. The implementation of rigorous control and"/>
  <result pre="the spread of this virus globally. The occurrence of COVID-19" exact="infection" post="on several cruise ships gave us a preliminary idea"/>
  <result pre="intervention strategies, such as large-scale testing, contract tracing, and localized" exact="quarantine" post="of suspected cases for limiting the spread of this"/>
  <result pre="system is not overloaded. The reproduction number (R0) of COVID-19" exact="infection" post="was earlier estimated to be in the range of"/>
  <result pre="it is a relief that the current outbreak of COVID-19" exact="infection" post="can be brought under control with the adoption of"/>
  <result pre="of strategic preventive and control measures along with the early" exact="isolation" post="of subsequent cases in the coming days. Studies also"/>
  <result pre="especially for developing countries, due to their inability to allocate" exact="quarantine" post="stations that could screen infected individualsâ€™ movements (234). Such"/>
  <result pre="of veterinary medicine, pharmacology, infectious diseases of animals, wildlife diseases," exact="diagnosis" post="and therapy of animal diseases, nutrition, and biomedicine. With"/>
  <result pre="focus on developing different molecular as well as serological diagnostic" exact="testing" post="assays. Apart from his expertise in viral diagnosis, he"/>
  <result pre="to viral disease epidemiology, virus-host interactions, microbial biodiversity, characterization, and" exact="diagnosis" post="of pathogens. He performed his postdoctoral work at the"/>
  <result pre="diseases with a focus on understanding the pathogenesis and molecular" exact="diagnosis" post="of viral diseases, with particular reference to rabies and"/>
  <result pre="6.FanY, ZhaoK, ShiZL, ZhouP2019Bat coronaviruses in China. Viruses11:210. doi:10.3390/v11030210. 7.LuH2020Drug" exact="treatment" post="options for the 2019-new coronavirus (2019-nCoV). Biosci Trends14:69â€&quot;71. doi:10.5582/bst.2020.01020.31996494"/>
  <result pre="locked-down Wuhan. Nature577:607. doi:10.1038/d41586-020-00190-6.31992886 20.DhamaK, PawaiyaRVS, ChakrabortS, TiwariR, SaminathanM, VermaAK2014Coronavirus" exact="infection" post="in equines: a review. Asian J Anim Vet Adv9:164â€&quot;176."/>
  <result pre="Care Med46:576â€&quot;578. doi:10.1007/s00134-020-05966-y.32077996 68.ChengVCC, WongSC, ToKKW, HoPL, YuenKY2020Preparedness and proactive" exact="infection" post="control measures against the emerging Wuhan coronavirus pneumonia in"/>
  <result pre="WangX, WangY, GaoL2020Diagnosis, treatment, and prevention of 2019 novel coronavirus" exact="infection" post="in children: expertsâ€™ consensus statement. World J Pediatr7:1â€&quot;9. doi:10.1007/s12519-020-00343-7."/>
  <result pre="World J Pediatr7:1â€&quot;9. doi:10.1007/s12519-020-00343-7. 81.LinL, LiTS2020Interpretation of guidelines for the" exact="diagnosis" post="and treatment of novel coronavirus (2019-nCoV) infection by the"/>
  <result pre="Pediatr7:1â€&quot;9. doi:10.1007/s12519-020-00343-7. 81.LinL, LiTS2020Interpretation of guidelines for the diagnosis and" exact="treatment" post="of novel coronavirus (2019-nCoV) infection by the National Health"/>
  <result pre="guidelines for the diagnosis and treatment of novel coronavirus (2019-nCoV)" exact="infection" post="by the National Health Commission (trial version 5). Zhonghua"/>
  <result pre="the 2019 novel coronavirus (COVID-19). Infect24:187. doi:10.22354/in.v24i3.848. 96.Wilder-SmithA, FreedmanDO2020Isolation, quarantine," exact="social distancing" post="and community containment: pivotal role for old-style public health"/>
  <result pre="MuÃ±ozMV, RajS, SchipperD, SolanesD, CordÃ³nI, BensaidA, HaagmansBL, SegalÃ©sJ2017Livestock susceptibility to" exact="infection" post="with Middle East respiratory syndrome coronavirus. Emerg Infect Dis23:232â€&quot;240."/>
  <result pre="A bibliometric analysis. Travel Med Infect Dis33:101566. doi:10.1016/j.tmaid.2020.101566.32007621 118.ZhouL, LiuHG2020Early" exact="detection" post="and disease assessment of patients with novel coronavirus pneumonia."/>
  <result pre="122.QiuHB, LiXY, DuB, KangHYJ, WangYS, WangF, SunB, TongZH2020The keypoints in" exact="treatment" post="of the critical novel coronavirus pneumonia patient. Zhonghua Jie"/>
  <result pre="doi:10.1002/jmv.25682.31967321 144.LiuP, ChenW, ChenJP2019Viral metagenomics revealed Sendai virus and coronavirus" exact="infection" post="of Malayan pangolins (Manisjavanica). Viruses11:979. doi:10.3390/v11110979. 145.XiaoK, ZhaiJ, FengY,"/>
  <result pre="ZhouJH, ZhangYZ, WangLF, DaszakP, ShiZL2018Serological evidence of bat SARS-related coronavirus" exact="infection" post="in humans, China. Virol Sin33:104â€&quot;107. doi:10.1007/s12250-018-0012-7.29500691 148.GaoZC2020Efficient management of"/>
  <result pre="novel coronavirus infection: proposal of conventional serologic assays for disease" exact="diagnosis" post="and infection monitoring. J Med Virol92:464â€&quot;467. doi:10.1002/jmv.25702.32031264 150.YuF, DuL,"/>
  <result pre="infection: proposal of conventional serologic assays for disease diagnosis and" exact="infection" post="monitoring. J Med Virol92:464â€&quot;467. doi:10.1002/jmv.25702.32031264 150.YuF, DuL, OjciusDM, PanC,"/>
  <result pre="ChoiCY, KandambyDH, LungDC, TamAR, PoonRW, FungAY, HungIF, ChengVC, ChanJF, YuenKY1222020Consistent" exact="detection" post="of 2019 novel coronavirus in saliva. Clin Infect Dis"/>
  <result pre="ChengSMS, HuiKPY, KrishnanP, LiuY, NgDYM, WanCKC, YangP, WangQ, PeirisM, PoonL2020Molecular" exact="diagnosis" post="of a novel coronavirus (2019-nCoV) causing an outbreak of"/>
  <result pre="YuenKY, collab: HKU/UCH SARS Study Group2004Role of lopinavir/ritonavir in the" exact="treatment" post="of SARS: initial virological and clinical findings. Thorax59:252â€&quot;256. doi:10.1136/thorax.2003.012658.14985565"/>
  <result pre="SunJ, TengY, WuM, LiJ, LiY, HuN, WangH, HuY2015Epitope-based vaccine target" exact="screening" post="against highly pathogenic MERS-CoV: an in silico approach applied"/>
  <result pre="QinC, YuenKY2015Treatment with lopinavir/ritonavir or interferon-Î²1b improves outcome of MERS-CoV" exact="infection" post="in a nonhuman primate model of common Marmoset. J"/>
  <result pre="Trials19:81. doi:10.1186/s13063-017-2427-0.29382391 192.collab: WHO. 2020Clinical management of severe acute respiratory" exact="infection" post="when novel coronavirus (nCoV) infection is suspected. Available onhttps://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected."/>
  <result pre="management of severe acute respiratory infection when novel coronavirus (nCoV)" exact="infection" post="is suspected. Available onhttps://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected. Accessed on 7 February 2020."/>
  <result pre="KsiazekTG, SeidahNG, NicholST2005Chloroquine is a potent inhibitor of SARS coronavirus" exact="infection" post="and spread. Virol J2:69. doi:10.1186/1743-422X-2-69.16115318 197.GaoJ, TianZ, YangX2020Breakthrough: chloroquine"/>
  <result pre="197.GaoJ, TianZ, YangX2020Breakthrough: chloroquine phosphate has shown apparent efficacy in" exact="treatment" post="of COVID-19 associated pneumonia in clinical studies. Biosci Trends14:72â€&quot;73."/>
  <result pre="human monoclonal antibody. Emerg Microbes Infect9:382â€&quot;385. doi:10.1080/22221751.2020.1729069.32065055 203.KilianskiA, BakerSC2014Cell-based antiviral" exact="screening" post="against coronaviruses: developing virus-specific and broad-spectrum inhibitors. Antiviral Res101:105â€&quot;112."/>
  <result pre="KuikenT, FouchierRA, RimmelzwaanGF, Van AmerongenG, PeirisJS, LimW, OsterhausAD2003Virology: SARS virus" exact="infection" post="of cats and ferrets. Nature425:915. doi:10.1038/425915a.14586458 214.LamirandeEW, DeDiegoML, RobertsA,"/>
  <result pre="HouW, ZhangY2020Clinical characteristics and intrauterine vertical transmission potential of COVID-19" exact="infection" post="in nine pregnant women: a retrospective review of medical"/>
  <result pre="YangX, ShiY, YangZ2020Comparison of different samples for 2019 novel coronavirus" exact="detection" post="by nucleic acid amplification tests. Int J Infect Dis93:264â€&quot;267."/>
  <result pre="Hepatol5:430â€&quot;432. doi:10.1016/S2468-1253(20)30082-0.32192627 251.XiaoF, TangM, ZhengX, LiuY, LiX, ShanH2020Evidence for gastrointestinal" exact="infection" post="of SARS-CoV-2. Gastroenterology158:1831â€&quot;1833. doi:10.1053/j.gastro.2020.02.055.32142773 252.YeoC, KaushalS, YeoD2020Enteric involvement of"/>
  <result pre="KimJM, ChungYS, KimHM, HanMG, KimSY, ChinBS2020Viral load kinetics of SARS-CoV-2" exact="infection" post="in first two patients in Korea. J Korean Med"/>
  <result pre="compared with SARS-CoV-1. N Engl J Med382:1564â€&quot;1567. doi:10.1056/NEJMc2004973.32182409 258.LoeffelholzMJ, TangYW2020Laboratory" exact="diagnosis" post="of emerging human coronavirus infectionsâ€&quot;the state of the art."/>
  <result pre="review on the efficacy and safety of chloroquine for the" exact="treatment" post="of COVID-19. Crit Care57:279â€&quot;283. doi:10.1016/j.jcrc.2020.03.005. 263.DevauxCA, RolainJM, ColsonP, RaoultD2020New"/>
  <result pre="and projection of optimized dosing design of hydroxychloroquine for the" exact="treatment" post="of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin"/>
  <result pre="a recommendation to examine the effect of hydroxychloroquine in preventing" exact="infection" post="and progression. J Antimicrob Chemother doi:10.1093/jac/dkaa114. 268.SrinivasaA, TosounidouS, GordonC2017Increased"/>
  <result pre="of Novel Coronavirus. 2020Expert consensus on chloroquine phosphate for the" exact="treatment" post="of novel coronavirus pneumonia. Zhonghua Jie He He Hu"/>
  <result pre="ChabriÃ¨reE, La ScolaB, RolainJM, BrouquiP, RaoultD2032020Hydroxychloroquine and azithromycin as a" exact="treatment" post="of COVID-19: results of an open-label non-randomized clinical trial."/>
  <result pre="pathogenesis, immunopathology and mitigation strategiesâ€&quot;a review. Preprintshttps://www.preprints.org/manuscript/202003.0348/v1. 283.KimberlinDW, StagnoS2632020Can SARS-CoV-2" exact="infection" post="be acquired in utero? More definitive evidence is needed."/>
  <result pre="TangY, GaoG, WangS, MaC, XieR, WangF, TanC, ZhuL, GuoY, ZhangF2832020Quantitative" exact="detection" post="and viral load analysis of SARS-CoV-2 in infected patients."/>
  <result pre="patients. Clin Infect Dis doi:10.1093/cid/ciaa345. 292.HuangY, ChengW, ZhaoN, QuH, TianJ2632020CT" exact="screening" post="for early diagnosis of SARS-CoV-2 infection. Lancet Infect Dis"/>
  <result pre="Dis doi:10.1093/cid/ciaa345. 292.HuangY, ChengW, ZhaoN, QuH, TianJ2632020CT screening for early" exact="diagnosis" post="of SARS-CoV-2 infection. Lancet Infect Dis doi:10.1016/S1473-3099(20)30241-3. 293.OuX, LiuY,"/>
  <result pre="2020. https://www.who.int/blueprint/priority-diseases/key-action/novel-coronavirus-landscape-ncov.pdf?ua=1. 299.CascellaM, RajnikM, CuomoA, DulebohnSC, Di NapoliR2020Features, evaluation and" exact="treatment" post="coronavirus (COVID-19)InStatPearls [Internet]. StatPearls Publishing, Treasure Island, FL. 300.ShettyR,"/>
  <result pre="ZhangX, YanX, ZengX, ZhangS2020The use of anti-inflammatory drugs in the" exact="treatment" post="of people with severe coronavirus disease 2019 (COVID-19): the"/>
  <result pre="plasma. JAMA323:1582. doi:10.1001/jama.2020.4783.32219428 311.KeithP, DayM, PerkinsL, MoyerL, HewittK, WellsA2020A novel" exact="treatment" post="approach to the novel coronavirus: an argument for the"/>
  <result pre="LiJ, TscharkeB, VerhagenR, SmithWJM, ZauggJ, DierensL, HugenholtzP, ThomasKV, MuellerJF2020First confirmed" exact="detection" post="of SARS-CoV-2 in untreated wastewater in Australia: a proof"/>
  <result pre="of ivermectin alone is not the ideal dose for the" exact="treatment" post="of COVID-19. Clin Pharmacol Ther18:630. doi:10.1002/cpt.1889. 341.BrayM, RaynerC, NoÃ«lF,"/>
  <result pre="2 April 2020. 345.AiJW, ZhangY, ZhangHC, XuT, ZhangWH2020Era of molecular" exact="diagnosis" post="for pathogen identification of unexplained pneumonia, lessons to be"/>
  <result pre="ZornK, GopezA, HsuE, GuW, MillerS, PanCY, GuevaraH, WadfordDA, ChenJS, ChiuCY1642020CRISPR-Cas12-based" exact="detection" post="of SARS-CoV-2. Nat Biotechnol doi:10.1038/s41587-020-0513-4. 347.ChengMP, PapenburgJ, DesjardinsM, KanjilalS,"/>
  <result pre="Biotechnol doi:10.1038/s41587-020-0513-4. 347.ChengMP, PapenburgJ, DesjardinsM, KanjilalS, QuachC, LibmanM, DittrichS, YansouniCP1352020Diagnostic" exact="testing" post="for severe acute respiratory syndrome-related coronavirus-2: a narrative review."/>
  <result pre="a novel reverse transcription loop-mediated isothermal amplification method for rapid" exact="detection" post="of SARS-CoV-2. Virol Sin doi:10.1007/s12250-020-00218-1. 350.PathakM, PatelSK, JigyasaR, TiwariR,"/>
  <result pre="WuS, HaoX, LiX, LiuX, YeS, HanH, DongX, LiX, LiJ2020Rapid colorimetric" exact="detection" post="of COVID-19 coronavirus using a reverse transcriptional loop-mediated isothermal"/>
  <result pre="(RT-LAMP) diagnostic plat-form: iLACO. medRxivhttps://10.1101/2020.02.20.20025874. 355.ZhangF, AbudayyehOO, GootenbergJS2020A protocol for" exact="detection" post="of COVID-19 using CRISPR diagnostics. Broad Institute, Cambridge, MA."/>
  <result pre="RileyRD, SchuitE, SmitsLJM, SnellKIE, SteyerbergEW, WallischC, van SmedenM2020Prediction models for" exact="diagnosis" post="and prognosis of Covid-19 infection: systematic review and critical"/>
 </snippets>
</snippetsTree>
